Follow
Ashkan Mortezavi, PD Dr. med.
Ashkan Mortezavi, PD Dr. med.
Universitätsspital Basel
Verified email at usb.ch
Title
Cited by
Cited by
Year
Periostin is up-regulated in high grade and high stage prostate cancer
V Tischler, FR Fritzsche, PJ Wild, C Stephan, HH Seifert, MO Riener, ...
BMC cancer 10 (1), 1-9, 2010
1252010
KPNA2 Expression Is an Independent Adverse Predictor of Biochemical Recurrence after Radical ProstatectomyKPNA2 Expression in Prostate Cancer
A Mortezavi, T Hermanns, HH Seifert, MK Baumgartner, M Provenzano, ...
Clinical cancer research 17 (5), 1111-1121, 2011
1032011
A positive family history as a risk factor for prostate cancer in a population‐based study with organised prostate‐specific antigen screening: results of the Swiss European …
M Randazzo, A Müller, S Carlsson, D Eberli, A Huber, R Grobholz, ...
BJU international 117 (4), 576-583, 2016
672016
The natural history of untreated muscle‐invasive bladder cancer
A Martini, JP Sfakianos, L Renström‐Koskela, A Mortezavi, UG Falagario, ...
BJU international 125 (2), 270-275, 2020
612020
MAGE-C2/CT10 protein expression is an independent predictor of recurrence in prostate cancer
L Von Boehmer, L Keller, A Mortezavi, M Provenzano, G Sais, ...
PloS one 6 (7), e21366, 2011
592011
Insulin-like growth factor II mRNA binding protein 3 (IMP3) is overexpressed in prostate cancer and correlates with higher Gleason scores
K Ikenberg, FR Fritzsche, U Zuerrer-Haerdi, I Hofmann, T Hermanns, ...
BMC cancer 10 (1), 1-6, 2010
492010
Direct comparison of PI-RADS version 2 and version 1 regarding interreader agreement and diagnostic accuracy for the detection of clinically significant prostate cancer
AS Becker, A Cornelius, CS Reiner, D Stocker, EJ Ulbrich, BK Barth, ...
European journal of radiology 94, 58-63, 2017
462017
Extensive histological sampling following focal therapy of clinically significant prostate cancer with high intensity focused ultrasound
A Mortezavi, J Krauter, A Gu, J Sonderer, J Bruhin, KA Reeve, L Held, ...
The Journal of Urology 202 (4), 717-724, 2019
432019
Diagnostic accuracy of multiparametric magnetic resonance imaging and fusion guided targeted biopsy evaluated by transperineal template saturation prostate biopsy for the …
A Mortezavi, O Märzendorfer, OF Donati, G Rizzi, NJ Rupp, MS Wettstein, ...
The Journal of urology 200 (2), 309-318, 2018
432018
External physical and biochemical stimulation to enhance skeletal muscle bioengineering
C Handschin, A Mortezavi, J Plock, D Eberli
Advanced drug delivery reviews 82, 168-175, 2015
412015
Genetic and epigenetic SLC18A2 silencing in prostate cancer is an independent adverse predictor of biochemical recurrence after radical prostatectomy
KD Sørensen, PJ Wild, A Mortezavi, K Adolf, N Tørring, S Heebøll, ...
Clinical Cancer Research 15 (4), 1400-1410, 2009
342009
68Ga-PSMA-11 PET/MR detects local recurrence occult on mpMRI in prostate cancer patients after HIFU
IA Burger, J Müller, OF Donati, DA Ferraro, M Messerli, B Kranzbühler, ...
Journal of Nuclear Medicine 60 (8), 1118-1123, 2019
312019
Prospective multicentre study using high intensity focused ultrasound (HIFU) for the focal treatment of prostate cancer: Safety outcomes and complications
FA Schmid, D Schindele, A Mortezavi, T Spitznagel, T Sulser, M Schostak, ...
Urologic Oncology: Seminars and Original Investigations 38 (4), 225-230, 2020
222020
Extraction strings for ureteric stents: is there an increased risk for urinary tract infections?
M Fröhlich, J Fehr, T Sulser, D Eberli, A Mortezavi
Surgical Infections 18 (8), 936-940, 2017
212017
Lithium triborate laser vaporization of the prostate using the 120 W, high performance system laser: high performance all the way?
T Hermanns, DD Strebel, LJ Hefermehl, O Gross, A Mortezavi, A Müller, ...
The Journal of urology 185 (6), 2241-2247, 2011
212011
External validation and comparison of prostate cancer risk calculators incorporating multiparametric magnetic resonance imaging for prediction of clinically significant …
K Saba, MS Wettstein, L Lieger, AM Hötker, OF Donati, H Moch, ...
The Journal of Urology 203 (4), 719-726, 2020
202020
The central zone has increased 68Ga-PSMA-11 uptake:“Mickey Mouse ears” can be hot on 68Ga-PSMA-11 PET
DA Pizzuto, J Müller, U Mühlematter, NJ Rupp, A Töpfer, A Mortezavi, ...
European journal of nuclear medicine and molecular imaging 45 (8), 1335-1343, 2018
182018
Continuous low-dose aspirin therapy in robotic-assisted laparoscopic radical prostatectomy does not increase risk of surgical hemorrhage
A Mortezavi, T Hermanns, LJ Hefermehl, DR Spahn, B Seifert, D Weber, ...
Journal of Laparoendoscopic & Advanced Surgical Techniques 23 (6), 500-505, 2013
182013
Combined N‐terminal androgen receptor and autophagy inhibition increases the antitumor effect in enzalutamide sensitive and enzalutamide resistant prostate cancer cells
B Kranzbühler, S Salemi, A Mortezavi, T Sulser, D Eberli
The Prostate 79 (2), 206-214, 2019
162019
Negative LC3b immunoreactivity in cancer cells is an independent prognostic predictor of prostate cancer specific death
A Mortezavi, S Salemi, NJ Rupp, JH Rüschoff, T Hermanns, C Poyet, ...
Oncotarget 8 (19), 31765, 2017
162017
The system can't perform the operation now. Try again later.
Articles 1–20